Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 70121-1237
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 70121-1237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ty (Azacitidine For Injection 2)
Container (Azacitidine For Injection 3)
This appears to be the label of a cytotoxic agent that is to be used only for subcutaneous and intravenous use. The agent has a dosage of 4100mg/vial and any unused portion should be discarded. The label also has some alphanumeric codes and other information, including a customer service phone number.*
Carton (Azacitidine For Injection 4)
This is a description of Azacitidine, an injection used for subcutaneous and intravenous administration. It is manufactured by Amneal Oncology Put. Ltd. in Telangana, India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Each sterile single-dose vial contains 100mg of azacitidine and mannitol. It is a cytotoxic agent used in cases described by a physician for dosage and administration. The drug should be kept out of the reach of children and stored at a temperature between 15° to 30°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.